SCHEMBL7658461

SCHEMBL7658461

CCOC(=O)N=C(N)c1ccc(NC(=O)c2ccccc2-c2ccccc2C(=O)OCC)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.56
ALDH1A1 P00352 6/20 0.56
RAB9A P51151 6/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
NPC1 O15118 4/20 0.56
GAA P10253 3/20 0.56
MAPK1 P28482 3/20 0.47
MAPT P10636 2/20 0.47
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.45
PKM P14618 1/20 0.45
KDM4E B2RXH2 2/20 0.45
MAOA P21397 1/20 0.44
TSHR P16473 1/20 0.44
CASP3 P42574 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663254 0.92 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7662346 0.92 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7661471 0.91 CYP3A4 (0.53) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7654193 0.91 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7657150 0.88 CYP3A4 (0.49) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7688990 0.86 F3 (0.63)
SCHEMBL7656002 0.86 RAB9A (0.45) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7657290 0.82 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7659362 0.79 CYP2C9 (0.51) ALDH1A1MEN1KMT2AGAAMAPK1
SCHEMBL7679600 0.78 F3 (0.66)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed